Wranke, A.Yurdaydin, C.Heidrich, B.Caruntu, F. A.Curescu, M. G.Yalçin, K.Zeuzem, S.Erhardt, A.Lueth, S.Papatheodoridis, G. V.Bremer, B.Stift, J.Grabowski, J.Kirschner, J.Port, K.Cornberg, M.Falk, C.Dienes, H. P.Hardtke, S.Manns, M. P.Wedemeyer, H.HIDIT-2 Study Grp2024-08-162024-08-162013-04-010168-8278https://hdl.handle.net/11452/44102Bu çalışma, 24-28, Nisan 2013 tarihleri arasında Amsterdam[Hollanda]’da düzenlenen International Liver Congress / 48. Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineGastroenterology & hepatologyAnti-hdv-igm as a marker of disease activity in hepatitis deltaMeeting Abstract000322983000436S178S17858Supplement1